| Akums Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544222 |
NSE Symbol : AKUMS |
P/E(TTM) : 48.90 |
|
ISIN Demat : INE09XN01023 |
Div & Yield% : 0.00 |
EPS(TTM) : 8.71 |
|
Book Value(₹) : 150.82 |
Market Cap(₹Cr) : 6,703.41 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 309.32 | 332.44 | 328.75 | 337.41 | 328.35 | 317.28 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 309.32 | 332.44 | 328.75 | 337.41 | 328.35 | 317.28 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 27.08 | 28.56 | 32.05 | 33.84 | 32.12 | 26.18 |
| Total Income | 336.39 | 361.00 | 360.80 | 371.25 | 360.47 | 343.45 |
| Total Expenditure | 292.42 | 288.34 | 311.03 | 303.38 | 285.28 | 273.59 |
| PBIDT | 43.97 | 72.66 | 49.77 | 67.87 | 75.19 | 69.86 |
| Interest | 2.08 | 2.91 | 2.63 | 2.29 | 4.18 | 6.21 |
| PBDT | 41.89 | 69.75 | 47.15 | 65.57 | 71.01 | 63.65 |
| Depreciation | 10.69 | 10.25 | 10.09 | 10.68 | 9.39 | 9.38 |
| Tax | 8.31 | 16.22 | 8.26 | 13.06 | 13.71 | 12.52 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.57 | -1.58 | 1.21 | 0.67 | -2.46 | -0.13 |
| Reported Profit After Tax | 23.46 | 44.87 | 27.59 | 41.17 | 50.37 | 41.88 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 23.46 | 44.87 | 27.59 | 41.17 | 50.37 | 41.88 |
| EPS (Unit Curr.) | 1.53 | 2.93 | 1.80 | 2.69 | 3.38 | 2.93 |
| EPS (Adj) (Unit Curr.) | 1.53 | 2.93 | 1.80 | 2.69 | 3.38 | 2.93 |
| Calculated EPS (Unit Curr.) | 1.53 | 2.93 | 1.80 | 2.69 | 3.29 | 2.93 |
| Calculated EPS (Adj) (Unit Curr.) | 1.53 | 2.93 | 1.80 | 2.69 | 3.29 | 2.93 |
| Calculated EPS (Ann.) (Unit Curr.) | 6.13 | 11.72 | 7.21 | 10.76 | 13.16 | 11.71 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 6.13 | 11.72 | 7.21 | 10.76 | 13.16 | 11.71 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 30.62 | 30.62 | 30.62 | 30.62 | 30.62 | 28.61 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 2,204.17 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 14.22 | 21.86 | 15.14 | 20.11 | 22.90 | 22.02 |
| PBDTM(%) | 13.54 | 20.98 | 14.34 | 19.43 | 21.63 | 20.06 |
| PATM(%) | 7.58 | 13.50 | 8.39 | 12.20 | 15.34 | 13.20 |